Recipharm Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Recipharm's estimated annual revenue is currently $916.2M per year.(i)
  • Recipharm's estimated revenue per employee is $201,000

Employee Data

  • Recipharm has 4558 Employees.(i)
  • Recipharm grew their employee count by 9% last year.

Recipharm's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
CEOReveal Email/Phone
3
CFO - Member the Executive CommitteeReveal Email/Phone
4
Group General Counsel, Chief Compliance Officer, ESG Head, Board SecretaryReveal Email/Phone
5
Head Legal (US), Chief Legal Officer & Corporate SecretaryReveal Email/Phone
6
Head Supply ChainReveal Email/Phone
7
Head Global Supply Chain & Customer Service VPReveal Email/Phone
8
Head Group Financial Planning and AnalysisReveal Email/Phone
9
Head scale up.Reveal Email/Phone
10
Head Quality Assurance. Qualified PersonReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.6M560%$6.3MN/A
Add Company

What Is Recipharm?

Recipharm is your partner for contract pharmaceutical development and manufacturing. With production facilities across Europe, we are uniquely positioned to deliver reliable and flexible service for all our customers, wherever you are. We supply several hundred different products in a variety of dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder inhalers and granulates, from our various facilities across Europe. Recipharm’s Pharmaceutical Development Services group activities a range from straight forward clinical supply through to more complex product development and formulation. From our pharmaceutical development centre we can work on a variety of technologies (including sterile products). Formulation Development, Clinical Supplies, Analytical Development, Stability Studies, Packaging Development and Raw Material Selection are all core activities. Pharmaceutical contract development and manufacturing

keywords:N/A

N/A

Total Funding

4558

Number of Employees

$916.2M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Recipharm News

2022-04-17 - CMO/CDMO Market Set to Witness Explosive Growth by 2029 ...

CMO/CDMO Market Set to Witness Explosive Growth by 2029 | Recipharm, AMRI3, Patheon · New Jersey, N.J. – · Get the PDF Sample Copy (Including FULL...

2022-04-17 - CMO/CDMO Market Set to Witness Explosive Growth by 2029 ...

CMO/CDMO Market Set to Witness Explosive Growth by 2029 | Recipharm, AMRI3, Patheon · New Jersey, N.J. – · Get the PDF Sample Copy (Including FULL...

2022-04-13 - Recipharm builds biologics presence with acquisitions

Recipharm entered the biologics market earlier this year with the acquisition of GenIbet, a Portuguese biopharmaceutical contract manufacturing...

2022-04-13 - Recipharm builds biologics presence with acquisitions

Recipharm entered the biologics market earlier this year with the acquisition of GenIbet, a Portuguese biopharmaceutical contract manufacturing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12980M53765%N/A
#2
$1775.2M8745N/AN/A
#3
$8550.7M226214%N/A
#4
$4980M280824%N/A
#5
$8865.2M427551%$850M